Solvonis Therapeutics' chief scientific officer, Professor David Nutt, will speak at the 14th Joint Meeting of US federal addiction research bodies on May 6, 2026. He is the sole external speaker at this NIH-coordinated event, discussing psychedelic therapy for addictions, which aligns with Solvonis' drug development programs for alcohol and stimulant use disorders. This highlights the company's relevance in cutting-edge addiction treatment research, although it does not imply official endorsement by US agencies.
Cyclr's benchmark study reveals that using a task-focused 'Thin MCP' server design can reduce AI token consumption by about 75% compared to a broad 'Thick MCP' design, while maintaining the same level of answer accuracy. The study tested configuratio...
Xcel Brands has signed a licensing agreement with KBL Group to produce ready-to-wear collections for OFF/DUTY by Coco Rocha, a fashion brand created with supermodel Coco Rocha. KBL Group will handle sourcing, product development, manufacturing, and s...
State Street Global Advisors & Affiliates disclosed an increase in their holdings of DCC plc ordinary shares to 1,194,093 shares, representing approximately 1.398% of the company. The purchases occurred on July 3, 2026, at a price of €60.90 per share...
Bath & Body Works introduced Fruit Fusion, a new body care franchise featuring fruit-inspired scents and hydrating formulas, available in the U.S. and Canada starting July 6, 2026. Actress Hilary Duff serves as the brand ambassador and creative partn...
The 32nd Global Family Office Investment Summit in Lake Como gathered over 200 family office leaders, investors, and entrepreneurs from 27 countries to discuss emerging trends in AI, private equity, healthcare innovation, and global investment opport...
